跳至主要内容
临床试验/NCT03665753
NCT03665753已完成早期 1 期

Comparison of Intravenous Ketorolac 10, 20, and 30mg for Treating Renal Colic Pain in the Emergency Department: A Randomized Controlled Trial

Tehran University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2018年11月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
165
试验地点
1
主要终点
Pain assessed with visual analogue scale (VAS)

研究概览

简要总结

Hypothesis: Intravenous administration of Ketorolac 10 mg and 20 mg is as effective as 30 mg in treating renal colic pain in patients presenting to the emergency department

详细描述

Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) that is widely used in the Emergency Department (ED). Because of the Ketorolac significant analgesic potency, it is usually used for moderate-to-severe pain. However, ketorolac has several side effects, of which gastrointestinal hemorrhage is most concerning. "Analgesic ceiling" is defined as the dose beyond which no additional analgesia can be achieved and on the other hand, more side effects might be encountered. Several studies suggested 10 mg as analgesic ceiling. Despite this, many recommendations are still advocating several folds higher doses (e.g. 30, 60 mg).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Severe flank and abdominal pain which pertains to renal colic according to emergency physician's gestalt

排除标准

  • Active Peptic Ulcer disease
  • Acute Gastrointestinal Hemorrhage
  • Known History of Renal or Hepatic insufficiency
  • History of allergies to NSAIDs

研究组 & 干预措施

Ketorolac 10mg

Experimental

Subjects will be administered 10 mg of Ketorolac.

干预措施: Ketorolac (Drug)

Ketorolac 20mg

Experimental

Subjects will be administered 20 mg of Ketorolac

干预措施: Ketorolac (Drug)

Ketorolac 30mg

Experimental

As a part of standard care, subjects will be administered 30 mg of Ketorolac.

干预措施: Ketorolac (Drug)

结局指标

主要结局

Pain assessed with visual analogue scale (VAS)

时间窗: 30 Minutes

The visual analogue scale (VAS) will be used for the study. The VAS ranges from 0 (no pain) to 100 (very severe pain). The higher the pain scores the higher the pain severity.

次要结局

  • Adverse Effects(60 Minutes)
  • Pain assessed with visual analogue scale (VAS)(60 Minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hadi Mirfazaelian

Assistant Professor of Emergency Medicine

Tehran University of Medical Sciences

研究点 (1)

Loading locations...

相似试验

Comparison of IV 10, 20, and 30mg for Renal Colic... | 临床试验